In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

OSI purchases drug discovery assets from Cadus

Executive Summary

Unable to carry on after losing its patent battle with Sibia Neurosciences over G-protein based assays in yeast, Cadus Pharmaceuticals has sold its other drug discovery assets to OSI Pharmaceuticals (drug discovery technology and biotech drugs) for $1.5mm.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
Deal Status
  • Final
Deal Type
  • Acquisition
    • Includes Earnout
    • Intra-Biotech Deal
    • Partial Acquisition
    • Payment Includes Cash

Related Companies

UsernamePublicRestriction

Register